Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Effect of Haemodialysis on the Antioxidative Properties of Serum (CROSBI ID 564662)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Wagner, Jadranka ; Milić, M. ; Sipl, I. ; Has-Schön, Elizabeta Effect of Haemodialysis on the Antioxidative Properties of Serum // Clinica chimica acta. 2005. str. S183-S184

Podaci o odgovornosti

Wagner, Jadranka ; Milić, M. ; Sipl, I. ; Has-Schön, Elizabeta

engleski

Effect of Haemodialysis on the Antioxidative Properties of Serum

Previous studies have shown that the most significant factor causing high mortality and high morbidity in patients with chronic renal disease is atherosclerosis. Although different risk factors have a role in the development of atherosclerosis the most important factors in CFR patients on haemodialysis are oxidative stress and dyslipidaemia. The aim of the study was to measure the effects of haemodialysis treatment on the general antioxidative status of serum with special reference to specific oxidizability of lipids and proteins. Indicators for oxidative/nonoxidative status of plasma were monitored at the beginning and at the end of the haemodialysis. A decrease in antioxidant status was accompanied by increased oxidizability of lipids as well as proteins during hemodialysis. Total antioxidant status decreased from 1.69±0.23 to 1.48±0.27 mmol/L ; homocysteine from 28.1±9.6 to 20.0±11.3 μmol/L ; C-reactive protein from 17.4±26.6 to 12.2±14.8 mg/L and Uric Acid from 370.6±71.2 to 108.8±32.6 μmol/L while there was an increase in albumin concentration from 37.7±3.7 to 42.9±5.9 g/L ; autoantibodies to oxidized LDL increased from 413.1±332.2 to 530.8±371.2 mU/ml ; HDL-C from 0.86±0.25 to 1.02±0.3 mmol/L ; LDL-C from 2.57±0.81 to 2.9±0.98 mmol/L. Our data demonstrate that the sensitivity of serum lipids and proteins to oxidative modification is increased by haemodialysis treatment.

haemodialysis; serum; antioxidative properties

doi:10.1016/j.cccn.2005.03.006

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

S183-S184.

2005.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Clinica chimica acta

0009-8981

Podaci o skupu

IFCC-FESCC European Congress of Clinical Biochemistry and Laboratory Medicine "Focus on the Patien" (16 ; 2005)

poster

08.05.2005-12.05.2005

Glasgow, Ujedinjeno Kraljevstvo

Povezanost rada

Kliničke medicinske znanosti, Biologija

Indeksiranost